Flagship-backed Cellarity raises another $121M for blood, metabolic disorders

Cellarity, the Flagship Pioneering upstart that has publicly declared a mission of eradicating ‘all diseases,’ has raised another $121 million as it makes headway on two disease areas in particular, blood and metabolic disorders.